Author

H. Hagen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:mouse· 1

Frequent Co-Authors

A. Amon· 1 shared A. Antebi· 1 shared A. Jurgens· 1 shared A. Martinez-Marti· 1 shared A. Villanueva· 1 shared C. McLean· 1 shared C. Roberts· 1 shared C.-W. Cheng· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Amon

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivOct 27, 2020

Cell size is a determinant of stem cell potential during aging

J. Lengefeld, C.-W. Cheng, P. Maretich…·A. Amon

The paper shows that stem cell enlargement during aging reduces their function, and preventing this enlargement improves function.

DOI 10.1126/sciadv.abk0271

𝕏 PostBluesky

Cancer BiologybioRxivOct 29, 2019

Multiple Low Dose therapy: an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours

J. M. Fernandes Neto, E. Nadal, S. N. Ooft…·R. Bernards

This paper shows that using multiple low doses of drugs targeting different components of a signaling pathway can effectively treat EGFR inhibitor-resistant NSCLC without resistance development.

DOI 10.1038/s41467-020-16952-9

humanexperimental assay

𝕏 PostBluesky